
News|Articles|March 1, 2009
Drug Watch: Agents in late-stage development for the treatment of pulmonary diseases (March 2009) (PDF)
Agents in late-stage development for the treatment of asthma, COPD, and PAH
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
3
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5
































